REED.AMEXReed's, INC

10-K: Reeds Inc. Reports Wider 2025 Loss Amid Sales Decline

Sentiment:

Annual Report


Reeds Inc. reported a significant increase in net loss for fiscal year 2025, driven by declining sales and higher operating expenses, despite strategic investments in Asia-Pacific expansion and recent capital raises.

Capital raiseOn December 4, 2025, the company entered into an underwriting agreement for a public offering of 2,500,000 shares of common stock and warrants to purchase up to 2,500,000 shares of common stock.The public offering closed on December 8, 2025, generating approximately $10.2 million in net proceeds after deducting underwriting discounts and expenses.The company granted underwriters a 45-day option to purchase an additional 375,000 shares and/or warrants, which was fully exercised in December 2025.Each warrant issued in the public offering has an exercise price of $4.50 per share and will expire on December 8, 2030.On September 12, 2025, the company completed a private placement of 833,330 shares of common stock at a purchase price of $6.00 per share, raising aggregate gross proceeds of $5.0 million.D&D Source of Life Holding Ltd., the controlling stockholder, participated in the December 2025 public offering, purchasing 1,250,000 shares of common stock and warrants to purchase 1,250,000 shares of common stock, and also purchased $1.0 million of common stock in a private placement that closed on June 4, 2025.The company intends to use the net proceeds from the public offering to fund growth initiatives, working capital, other general corporate purposes, and potentially for debt repayment.
Worse than expectedNet loss widened by 20% to $15.842 million in 2025.Net sales decreased by 10% in 2025, while the overall market grew.Gross profit declined by 39% and gross margin fell from 30% to 20%.Cash used in operations increased significantly to $17.037 million.Significant inventory write-offs of $2.013 million.

Summary

  • Net loss widened by 20% to $15.842 million in 2025, compared to $13.152 million in 2024.
  • Gross billing decreased by 8% to $40.847 million in 2025, from $44.316 million in 2024.
  • Net sales decreased by 10% to $34.065 million in 2025, from $37.954 million in 2024.
  • Gross profit declined by 39% to $6.962 million in 2025, with gross margin falling from 30% to 20%.
  • Operating expenses increased by 13% to $22.110 million in 2025, primarily due to higher selling, marketing, and general & administrative costs.
  • The company incurred $2.013 million in inventory write-offs in 2025, related to product portfolio optimization by new management.
  • Cash used in operating activities increased to $17.037 million in 2025, up from $6.124 million in 2024.
  • Successfully raised approximately $10.2 million net proceeds from a public offering in December 2025, and $5.0 million from a private placement in September 2025.
  • Effected a 1-for-6 reverse stock split on October 31, 2025.
  • Expanded into new geographic markets in the Asia-Pacific region by forming Reeds (Asia) Limited and five additional subsidiaries.
  • Amended its Senior Secured Loan agreement, reducing the revolving credit commitment to $9.25 million and extending the maturity date to September 30, 2026.
  • An arbitration with former related party California Custom Beverage, LLC resulted in an interim award in favor of the company in February 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing negatively due to significant declines in sales and profitability, coupled with increased operating losses and cash burn, despite successful capital raises and strategic international expansion efforts.

Positives

  • Successfully raised approximately $10.2 million net proceeds from a public offering in December 2025, and $5.0 million from a private placement in September 2025, bolstering liquidity.
  • Initiated strategic international expansion into the Asia-Pacific region by forming Reeds (Asia) Limited and five subsidiaries, aiming for long-term growth.
  • Launched a new multi-functional soda line in 2025, formulated with organic ingredients, adaptogen mushroom extracts, and prebiotic fiber, aligning with health-conscious consumer trends.
  • Maintained compliance with the financial covenants of its Senior Secured Loan agreement as of December 31, 2025.
  • The asset-light business model, relying on independent co-packers and distributors, provides scalability and flexibility without significant capital expenditures.

Negatives

  • Net loss widened by 20% to $15.842 million in 2025, indicating a worsening financial performance.
  • Gross billing decreased by 8% and net sales decreased by 10% in 2025, reflecting a decline in product demand and market penetration.
  • Gross profit decreased significantly by 39% and gross margin fell from 30% to 20% in 2025, primarily due to lower volumes and higher promotional allowances.
  • Operating expenses increased by 13% in 2025, outpacing sales and contributing to the wider loss from operations.
  • Incurred substantial inventory write-offs of $2.013 million in 2025, indicating challenges in inventory management and product portfolio effectiveness.
  • Cash used in operations increased to $17.037 million in 2025, highlighting a significant cash burn from core business activities.
  • No remaining availability under the Senior Secured Loan as of December 31, 2025, limiting immediate access to additional debt financing.
  • The company remains dependent on a limited number of customers, with the three largest comprising 21%, 15%, and 14% of net sales in 2025, posing concentration risk.
  • A valuation allowance is maintained against deferred tax assets due to a history of net operating losses, indicating uncertainty about future profitability.

Risks

  • The company has incurred and may continue to incur losses, and there is no guarantee of achieving or maintaining profitability.
  • Current and future indebtedness may contain restrictions on business operations and impair the ability to secure additional financing on favorable terms.
  • Demand for products can fluctuate significantly, and management's estimates of future product demand may be inaccurate, leading to product shortages or surplus.
  • Reduced demand for some products may occur due to health concerns (e.g., obesity) and legislative initiatives against sweetened beverages (e.g., sugar taxes).
  • Supply chain challenges, including labor shortages, raw material cost inflation, logistics issues, and increased freight costs, could disrupt operations and adversely affect financial performance.
  • Damage to reputation or brand image from product quality issues, non-compliance, or problematic content from social media influencers can adversely affect the business.
  • Inability to compete effectively against larger companies with significantly more financial resources could adversely affect sales and profitability.
  • Dependence on a limited number of customers for most of the revenue means the loss of, or significant reduction in orders from, key customers would severely impact the business.
  • Expansion into new international markets may face difficulties due to unpredictable taste preferences, increased competition, and political/legal challenges.
  • Performance significantly depends on key personnel; the loss of whom could affect operations and ability to manage the business.
  • Reliance on information technology systems exposes the company to risks of cyber-attacks, data breaches, or other disruptions, potentially leading to financial and reputational damage.
  • Failure to comply with evolving personal data protection and privacy laws (e.g., CCPA, CPRA, GDPR) can result in litigation, fines, or reputational harm.
  • An increase in the effective tax rate or new taxes aimed at products could adversely affect business or financial performance.
  • Limitations on the marketing or sale of products due to ingredients, packaging, or health concerns could reduce demand and lead to negative publicity.
  • The manufacturing process is not patented, relying on confidentiality agreements, which poses a risk if competitors obtain access to proprietary information.
  • Inability to adequately protect intellectual property rights, or being found to infringe on the intellectual property rights of others, can adversely affect the business.
  • Potential liabilities and costs from litigation, claims, legal or regulatory proceedings, inquiries, or investigations are inherent in the business.
  • Regulations concerning alcohol beverages may adversely affect the business, financial condition, or results of operations.
  • Significant changes to or failure to comply with various environmental laws may expose co-packers to liability or cause production disruptions.
  • Water scarcity and poor quality could negatively impact costs and production capacity.
  • Climate change and legal or regulatory responses thereto may have a long-term adverse impact on the business and results of operations.
  • The market price of common stock has been and may continue to be volatile or may decline regardless of operating performance.
  • Principal stockholders own a significant percentage of stock and can exert significant control over matters subject to stockholder approval.
  • Sales of a substantial number of shares of common stock in the public market could cause the stock price to fall.
  • The largest stockholder's preemptive right could dissuade a strategic investor from making an investment in the company.
  • The company does not intend to pay dividends for the foreseeable future, meaning stockholders' return depends solely on stock price appreciation.
  • Failure to meet the continued listing requirements of NYSE American could result in a de-listing of common stock.
  • As a controlled company, the company may rely on exemptions from certain NYSE American corporate governance requirements, potentially reducing protections for stockholders.
  • As a smaller reporting company, reduced reporting requirements may make common stock less attractive to investors.

Future Outlook

The company expects continued investment in its Asia-Pacific growth initiative and aims to fund its operating plan for at least twelve months from the financial statement issuance date using existing cash, cash from operations, and committed financing. Management is also taking actions to improve operating performance and cash generation, including product portfolio optimization, increasing sales, streamlining operations, improving supply chains, negotiating vendor contracts, and managing product pricing. However, there is no assurance that additional financing will be available on favorable terms or that these actions will be successful in a timely manner.

Management Comments

  • We intend to continue to expand, grow and develop our business, which may require additional capital to develop new products, enhance our platform, expand distribution, improve our operating infrastructure, react to market conditions and finance working capital requirements.
  • Management expects that the Company's existing cash of $10,424, cash generated from operations, and access to committed financing will be sufficient to fund the Company's operating plan, which was approved by the board of directors in February 2026, for at least twelve months from the date of issuance of the financial statements.
  • The Company is also continuing to take actions to improve the Company's operating performance and cash generated from operations, including product portfolio optimization, implementing strategies to increase sales, streamlining operations, improving supply chains, negotiating equitable vendor contracts, and managing product price architecture.
  • We believe this structure allows us to scale production efficiently, expand distribution, and introduce innovation without significant capital expenditures.
  • We believe international markets represent a significant long-term growth opportunity.

Industry Context

StockSavvy.ai notes that Reeds operates within the U.S. carbonated soft drink (CSD) market, which grew approximately 2% to $46 billion in 2025, and the U.S. ginger ale market, which grew approximately 6% to $2.9 billion in 2025. The company's focus on natural, premium, and functional beverages aligns with broader consumer trends for healthier options, reduced sugar, clean labels, and non-alcohol alternatives, which are expanding at double-digit rates. However, the company faces intense competition from both large international beverage companies and smaller craft brands, many of whom have greater financial resources and established market recognition. The RTD alcohol category, which Reeds entered in 2021, has seen significant growth, driven by consumer demand for convenience, quality, and less sugar, a trend Reeds is positioned to leverage.

Comparison to Industry Standards

  • Reeds' gross margin of 20% in 2025 is significantly lower than typical industry leaders in the beverage sector, which often achieve gross margins of 40-60% or higher (e.g., Coca-Cola, PepsiCo). This suggests a less efficient cost structure or aggressive pricing strategies.
  • The 10% decline in net sales for Reeds contrasts with the overall U.S. CSD market growth of 2% and U.S. ginger ale market growth of 6% in 2025, indicating a loss of market share or underperformance relative to industry trends.
  • The substantial inventory write-offs of $2.013 million in 2025, attributed to product portfolio optimization, suggest challenges in demand forecasting and inventory management, which could be higher than industry best practices for established beverage companies.
  • The company's asset-light model, relying on co-packers and third-party distributors, is a common strategy for smaller brands to scale, but it also introduces reliance risks that larger, vertically integrated competitors like Keurig Dr Pepper or Monster Beverage may mitigate through owned production and distribution.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Interim Chief Executive Officer, DirectorCyril A. Wallace, Jr.Neal M. CohaneMarch 24, 2026Cyril A. Wallace, Jr. resigned from the positions of Chief Executive Officer and director.
Chief Operating OfficerNANeal M. CohaneJanuary 2026Appointment to support growth strategy.
Chief Financial OfficerNADouglas W. McCurdyFebruary 10, 2025Appointment to the role.
Chief Executive Officer & Director of Reeds (Asia) Limited (BVI)NAYumin DaiFebruary 2025Appointment as part of strategic expansion into the Asia-Pacific region.
Chairperson of the BoardVice Chairperson of the BoardShufen DengNovember 2024Promotion from Vice Chairperson of the Board.
DirectorNASam VanOctober 2024Appointed pursuant to the director designation right granted to D&D Source of Life Holding Ltd.
DirectorNARudolf J. M. BakkerApril 11, 2025Appointment to the board.
DirectorNAMichael C. TuSeptember 2025Appointed pursuant to the director designation right granted to D&D Source of Life Holding Ltd.
Former Chief Executive OfficerNorman E. Snyder, Jr.NAApril 16, 2025Retirement from the position.
DirectorLewis JaffeNAMarch 31, 2025Resignation from the board.
DirectorRandle Lee EdwardsNASeptember 10, 2025Resignation from the board.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe board of directors has five directors, with three identified as independent. The company intends to maintain at least a majority of independent directors.March 25, 2026Aims to ensure independent oversight, but as a controlled company, it may rely on exemptions from certain NYSE American corporate governance requirements, potentially reducing protections for minority shareholders.
Committee MembershipThe Audit Committee is composed of Sam Van (Chair) and Michael C. Tu, both independent directors, with Sam Van qualifying as an audit committee financial expert. Rudolf J. M. Bakker chairs the Compensation Committee, and Michael C. Tu chairs the Nominating and Corporate Governance Committee.March 25, 2026Strengthens financial oversight and governance structure with independent experts, though the 'controlled company' status allows for less stringent independence requirements for some committees.
Shareholders Agreement AmendmentAn amendment to the Shareholders Agreement with D&D Source of Life Holding Ltd. (controlling stockholder) formalizes D&D's right to designate three directors (two of whom must be independent) and one board observer, and limits the board size to nine members without D&D's consent.January 24, 2025Grants significant control to D&D over board composition and strategic decisions, potentially impacting the independence of the board and the interests of other shareholders.
Board Observer AgreementThe company entered into a Board Observer Agreement governing D&D's right to designate a board observer (Yumin Dai), allowing attendance at board meetings and participation in discussions, with indemnification and expense reimbursement.January 24, 2025Increases D&D's influence and access to information, potentially impacting board dynamics and decision-making, especially given the observer is the spouse of the Chairperson.
Code of EthicsThe company has adopted a Code of Ethics applicable to all officers, directors, and employees, which is posted on its website.NA (already adopted)Promotes ethical conduct and compliance, enhancing corporate integrity.
Insider Trading PolicyThe company has adopted an insider trading policy and procedures governing securities transactions by directors, officers, and employees.NA (already adopted)Aims to prevent illegal insider trading and maintain market integrity, though the filing notes some Section 16(a) reports were not timely filed.
Clawback PolicyThe board of directors has adopted a written compensation recovery policy in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act and applicable exchange rules.NA (already adopted)Aligns executive compensation with financial performance and accountability, allowing for recovery of incentive-based compensation in certain circumstances.

Legal Proceedings

  • In January 2024, California Custom Beverage, LLC (CCB) filed an arbitration demand alleging claims against the company for various disputed amounts, to which the company filed a counter-demand. The cases were consolidated.
  • In February 2026, the arbitration resulted in an interim award in favor of the company. The interim award will become a final award after a final determination of costs and prejudgment interest.
  • On July 1, 2025, the company entered into a settlement and release agreement related to an engagement letter with an investment bank, paying $1.6 million for services rendered.
  • Management believes there are no other material pending legal proceedings that, if determined adversely, would have a material adverse effect on the company's financial position, results of operations, or cash flows.

Related Party Transactions

  • D&D Source of Life Holding Ltd. (D&D), the company's controlling stockholder, invested $3.0 million in SAFE vehicles on February 28, 2024, which reaffirmed D&D's director designation rights and board size limit.
  • On September 10, 2024, D&D subscribed for 3,268,795 shares of common stock in a private placement, converting its $3.0 million SAFE and paying an additional $1.903 million in cash.
  • On October 10, 2024, D&D acquired Whitebox Advisors' entire interest in eight secured promissory notes from the company for $17.878 million.
  • On November 14, 2024, D&D amended the Whitebox Notes, releasing collateral, deferring cash payments, extending maturity dates to May 14, 2026, and subordinating its notes to Whitebox's new $10.0 million term loan.
  • On November 19, 2024, D&D equitized the Whitebox Notes for 22,478,074 shares of common stock, with the excess of the converted value over the fair value ($2.248 million) treated as a capital contribution.
  • Era Regenerative Medicine Ltd. (ERM), the sole shareholder of D&D, acquired 367,647 shares of common stock on December 30, 2024, in a private placement.
  • On January 24, 2025, the company amended its Shareholders Agreement with D&D, formalizing D&D's right to designate three directors (two independent) and one board observer (Yumin Dai).
  • On May 28, 2025, D&D purchased $1.0 million of common stock in a private placement that closed on June 4, 2025.
  • D&D participated in the public offering on December 4, 2025, purchasing 1,250,000 shares of common stock and warrants to purchase 1,250,000 shares of common stock.
  • John J. Bello, the former Chairman and a significant stockholder, funded $300,000 through a SAFE investment in March 2023, which converted into 300,000 shares of common stock on September 10, 2024.
  • Norman E. Snyder, Jr., the then-serving CEO, provided a personal guaranty for $500,000 over advance on the company's line of credit on July 26, 2024, which was repaid by September 30, 2024.
  • Yumin Dai, spouse of Shufen Deng (Chairperson of the Board and D&D's non-independent designee), was appointed CEO of Reeds (Asia) Limited (BVI) on February 4, 2025, with an annual salary of $300,000 and reimbursement for automobile and housing expenses. He was also designated as D&D's board observer.

Stakeholder Impact

  • Shareholders: Experienced significant dilution from multiple equity raises and a reverse stock split. The widening net loss and declining gross margin could negatively impact stock price appreciation. The concentration of ownership by D&D and its preemptive rights could limit influence for other shareholders.
  • Employees: The company is investing in personnel to support growth initiatives, but the overall financial losses and cost optimization efforts could create uncertainty. Equity compensation plans are in place to incentivize performance.
  • Customers: New product innovations (multi-functional soda line) and expansion of distribution channels aim to enhance product availability and choice. However, potential supply chain disruptions and price increases could affect customer satisfaction.
  • Suppliers/Co-packers: The company relies heavily on a network of independent co-packers and suppliers. Efforts to streamline operations and negotiate equitable vendor contracts could impact these relationships. Supply chain constraints and raw material cost fluctuations pose risks.
  • Creditors: The Senior Secured Loan has restrictive covenants and requires minimum cash balances. While the company was in compliance as of December 31, 2025, continued operating losses could strain liquidity and impact ability to service debt.

Next Steps

  • Expand distribution and market penetration across mass, club, convenience, and liquor channels, and expand the national DSD network.
  • Leverage newly formed Asia-Pacific subsidiaries to expand further into international markets.
  • Enhance operational efficiency and reduce costs by transitioning packaging to aluminum cans, optimizing the co-packer network, and utilizing consolidated freight and logistics services.
  • Expand the healthier soda line with new SKUs and flavors, continuing to introduce beverages that align with health-conscious consumer trends.
  • Management will continue to monitor pricing and availability in transportation to manage freight cost risks.
  • Management will periodically evaluate various funding alternatives and may seek to raise additional funds through equity, mezzanine, or debt securities, strategic partnerships, or credit from financial institutions.
  • Continue actions to improve operating performance and cash generation, including product portfolio optimization, implementing strategies to increase sales, streamlining operations, improving supply chains, negotiating equitable vendor contracts, and managing product price architecture.
  • Await the final determination of costs and prejudgment interest in the arbitration with California Custom Beverage, LLC.

Key Dates

DateDescription
1987Reeds Original Ginger Brew created.
1989Reeds Original Ginger Brew introduced to market in Southern California stores.
1991Incorporated business operations under laws of Florida as Original Beverage Corporation.
1994Virgils first Handcrafted soda launched.
September 2001Reincorporated to Delaware and changed name to Reeds, Inc.
June 30, 2008Company gained right, but not obligation, to redeem Series A Convertible Preferred Stock.
December 2018Signed co-packing agreement with California Custom Beverage, LLC (CCB).
2019Streamlined focus to core brands: Reeds Ginger Beverages and Virgils Craft Sodas.
January 1, 2020California Consumer Privacy Act (CCPA) became effective.
March 1, 2020Amended and Restated Employment Agreement with Norman E. Snyder, Jr. became effective.
March 2020Start of Covid-19 pandemic, impacting RTD category.
September 2020Norman E. Snyder, Jr.'s base salary increased to $350,000.
December 19, 20202020 Equity Incentive Plan approved by shareholders.
December 21, 20202020 Equity Incentive Plan approved by shareholders.
2021Entered alcohol space with launch of RTD Classic Mule (7% ABV) and RTD Hard Ginger Ale (5% ABV).
March 2023John J. Bello funded $300,000 through a SAFE investment.
May 25, 2023Shareholders Agreement with D&D Source of Life Holding Ltd. dated.
July 2023Shufen Deng joined the board of directors.
December 2023Douglas W. McCurdy served as Director for Roberts & Ryan, Inc. until January 2025.
January 1, 2023California Privacy Rights Act (CPRA) took effect.
January 2024CCB filed arbitration demand against the Company; Company filed counter-demand.
February 2024Shufen Deng served as Vice Chairperson of the Board until November 2024.
February 12, 2024Limited Waiver, Deferral, and Amendment and Restatement Agreement with holders and collateral agent.
February 28, 2024D&D invested $3.0 million in SAFE vehicles.
April 1, 2024Amendment to Limited Waiver, Deferral, and Amendment and Restatement Agreement.
April 29, 20242024 Inducement Plan approved by compensation committee.
May 10, 2024Entered into long-term non-cancellable lease agreement for new office facility.
May 17, 2024Limited Waiver and Deferral Agreement with holders and collateral agent.
June 30, 2024SAFE investments recorded as a liability at $5.490 million.
July 26, 2024Norman E. Snyder Jr. provided personal guaranty for $500,000 over advance on credit line.
September 9, 2024Entered into Securities Purchase Agreement for issuance of 666,667 common shares for $6.0 million.
September 10, 2024D&D subscribed for 3,268,795 shares of common stock in a private placement; John J. Bello's SAFE converted into 300,000 shares.
September 30, 2024Over advance on credit line repaid.
October 10, 2024Whitebox Advisors, LLC sold and assigned interest in eight secured promissory notes to D&D for $17.878 million.
October 2024Sam Van joined the Board.
November 2024Shufen Deng became Chairperson of the Board.
November 14, 2024Entered into new secured one-year term loan with Whitebox for $10.0 million.
November 18, 2024Lease Commencement Date Notice and Agreement for office space.
November 19, 2024Entered into exchange agreement with D&D to equitize Whitebox Notes for 22,478,074 shares of common stock; Second Amendment and Partial Termination of Lease signed.
December 1, 2024Lease for principal executive office commenced.
December 30, 2024Entered into Securities Purchase Agreement with accredited investors, issuing 2,450,980 shares for $10.0 million; ERM acquired 367,647 shares.
December 31, 2024Fiscal year end; Allowance for credit losses $859 thousand; Inventory write-downs $277 thousand; Senior secured loan outstanding $9.9 million; Cash balance $10.391 million.
January 1, 2025New fiscal year begins.
January 24, 2025Amended Shareholders Agreement with D&D; Entered into Board Observer Agreement with D&D.
January 31, 2025Entered into Employment Agreement with Douglas W. McCurdy.
February 4, 2025Yumin Dai appointed CEO of Reeds (Asia) Limited (BVI).
February 10, 2025Douglas W. McCurdy commenced employment as CFO.
February 2025Board of directors approved operating plan for at least twelve months from financial statement issuance date.
March 2025Neal M. Cohane served as Chief Sales Officer at Eastroc Beverage until December 2025.
April 3, 2025SAFE investments converted to 12,778 shares of common stock.
April 10, 2025First Amendment of Lease signed.
April 11, 2025Rudolf J. M. Bakker appointed to the board.
April 16, 2025Cyril A. Wallace, Jr. commenced employment as CEO; Norman E. Snyder, Jr. retired as CEO; Entered into transition and separation agreement with Mr. Snyder.
May 28, 2025Entered into Securities Purchase Agreement with certain accredited investors, including D&D, for $3.0 million of common stock.
May 31, 2025Norman E. Snyder, Jr. ceased employment.
June 4, 2025Private placement of 537,632 shares of common stock for $3.0 million closed.
June 10, 2025Schedule 13D filed by D&D and Era Regenerative Medicine Ltd.
June 30, 2025Aggregate market value of non-affiliate common equity was $18,457,633.
July 1, 2025Entered into settlement and release agreement with an investment bank, paying $1.6 million.
September 2025Michael C. Tu joined the Board.
September 10, 2025Randle Lee Edwards resigned from the board.
September 12, 2025Entered into securities purchase agreement for private placement of 833,330 shares for $5.0 million.
September 15, 2025Private placement of 833,330 shares for $5.0 million closed.
September 19, 2025Registration statement for resale of September 2025 private placement shares filed.
September 26, 2025Entered into first amendment to Senior Secured Loan and Security Agreement.
September 29, 2025Registration statement for resale of September 2025 private placement shares declared effective.
October 31, 2025Effected a 1-for-6 reverse stock split.
November 19, 2025Second Amendment and Partial Termination of Lease signed.
December 4, 2025Entered into underwriting agreement for public offering of 2,500,000 shares and warrants; Registration statement on Form S-1 declared effective.
December 5, 2025Common Stock began trading on NYSE American LLC; Underwriters partially exercised Overallotment Option for warrants.
December 8, 2025Public offering closed.
December 12, 2025Underwriters exercised remaining Overallotment Option for common stock.
December 31, 2025Fiscal year end; Net loss $15.842 million; Cash balance $10.424 million; Senior secured loan outstanding $9.25 million; Inventory write-offs $2.013 million; Allowance for credit losses $980 thousand.
January 2026Neal M. Cohane served as Chief Operating Officer.
February 2026Arbitration with California Custom Beverage, LLC resulted in interim award in favor of the Company.
March 1, 2026Beneficial ownership calculation date.
March 20, 2026Total of 11,820,429 shares of Common Stock outstanding.
March 24, 2026Cyril A. Wallace, Jr. resigned as CEO and director; Neal M. Cohane appointed interim CEO and director.
March 25, 2026Report filing date.
March 31, 2026Cyril A. Wallace, Jr. to remain an employee through this date.
September 30, 2026Maturity date of Senior Secured Loan.
April 30, 2028Unvested stock options compensation expense recognition end date.
December 8, 2030Expiration date for warrants issued in the December 2025 public offering.
November 30, 2035Expiration date of office lease.

Recommendation

sell

The company's financial performance in 2025 shows significant deterioration, with a widening net loss, declining sales, and a substantial drop in gross margin. Despite successful capital raises, the increased cash burn from operations and the ongoing history of net operating losses raise serious concerns about long-term profitability and sustainability. The heavy reliance on a few key customers, unpatented manufacturing processes, and intense competition further exacerbate the risk profile. While strategic expansion into Asia-Pacific and new product innovation are positive, the current financial trajectory suggests a challenging path to profitability, making the stock a high-risk investment with a strong likelihood of further price decline.

Keywords

Reeds Inc., beverages, ginger beer, craft soda, SEC filing, 10-K, financial results, net loss, gross margin, capital raise, public offering, private placement, reverse stock split, Asia-Pacific expansion, supply chain, corporate governance, NYSE American, consumer trends, natural ingredients, functional beverages, RTD alcohol, debt financing, stock volatility

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.